Conroe · Houston · Fulshear · Katy · Kingwood  |  Telehealth in TX, NC & SC — Care From HomeCall or text 713-BOTOX-ME (713-268-6963)

Home / Treatment Library / Sermorelin Therapy

Peptide therapy

Physician-Supervised Sermorelin Therapy

Evidence, sourcing and supervision first. What sermorelin is, where it stands with the FDA, who may be a candidate, what the risks are, and what happens at a consultation — in Greater Houston and by telehealth across Texas, North Carolina and South Carolina.

Reviewed October 1, 2026
The short answer

What sermorelin is

Sermorelin is a laboratory-made version of the first 29 amino acids of growth hormone–releasing hormone (GHRH). It acts on the pituitary gland, signalling it to release the body's own growth hormone, rather than supplying growth hormone directly.

Whether it is appropriate for you is a clinical question, not a consumer one. It depends on a medical evaluation, laboratory testing and a documented clinical goal. A prescription is required, and it is written by a licensed clinician or not at all.

Reasons people ask about it

  • A medical question about growth hormone signalling that deserves evaluation and laboratory testing
  • Wanting the difference between an FDA-approved medicine and a compounded preparation explained plainly
  • Concern about where a prescribed product is actually made and how it is verified
  • Having read claims online and wanting them checked before buying or self-injecting anything
Regulatory status

Where sermorelin stands with the FDA

This is the part most pages about sermorelin leave vague. The dates matter, so they are stated plainly.

The approval history

Sermorelin acetate was approved by the FDA in 1997 under the brand name Geref, indicated for children with growth hormone deficiency. The manufacturer later stopped producing it for commercial reasons. In a determination published in the Federal Register on March 4, 2013, the FDA recorded that Geref was not withdrawn from sale for reasons of safety or effectiveness.

That distinction is narrow and worth understanding: it is a statement about why a product left the market, not an endorsement of any use of sermorelin today.

What that means now

There is no FDA-approved sermorelin product on the United States market. When a clinician prescribes it, the medication is prepared by a licensed compounding pharmacy. Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or manufacturing quality.

Use in adults for general wellness goals is off-label and is not supported by an FDA approval. We say so here rather than in a footnote, because it should change how you weigh the decision.

Our sourcing policy

We prescribe only through state-licensed compounding pharmacies we have verified, and we document which pharmacy fills a given prescription. We will not prescribe, administer or recommend any product labelled “research use only”, and we will not work from a vial a patient has obtained elsewhere.

Read our pharmacy sourcing and medication safety policy · How to evaluate a sermorelin product

Candidacy

Who may — and may not — be a candidate

Who may be considered

Adults with a legitimate clinical goal identified by a licensed clinician, after a health history, a physical evaluation and baseline laboratory testing, with a written monitoring plan and documented stopping rules.

When treatment may not be appropriate

Pregnancy or breastfeeding; a known allergy to sermorelin; untreated hypothyroidism; active cancer, or a history that raises a cancer concern; certain endocrine or pituitary conditions; and any medicine or condition your clinician identifies during review. A product obtained without a prescription, or from a source that cannot be verified, is never appropriate.

At a glance

Treatment facts

Planning information, not promises. Your consultation determines the actual plan.

Consultation
Usually 30–60 minutes, plus baseline laboratory testing
How it is given
A small subcutaneous injection, typically at bedtime, after in-office teaching
Downtime
None expected; possible side effects are listed below
When changes may appear
No universal timeline; reviewed against your laboratory results and goals at follow-up
How long it continues
Only while benefit, safety and lawful access continue to justify it
Monitoring
Scheduled follow-up and repeat laboratory testing, set by your clinician
Your visit

How a decision is reached

1. Evaluate

A physician reviews your symptoms, history, medicines and goals, orders laboratory testing, and checks whether an established treatment should be tried first. Sometimes the answer at this stage is that sermorelin is not the right question.

2. Plan

If sermorelin is reasonable, we go through its regulatory status, what the evidence does and does not support, the risks, the verified pharmacy and the cost with you — before anything is prescribed.

3. Follow up

The prescription, dose, monitoring schedule and stopping rules are documented. You are taught injection technique, told what to watch for, and told when to call us.

Risks and limitations

What you should weigh before deciding

This section stays on the page, in plain sight, rather than behind a tab.

Possible side effects

Injection-site redness, swelling, pain or itching; headache; flushing; nausea; dizziness; sleepiness; changes in taste; rash. Allergic reactions are possible. Tell us immediately about hives, difficulty breathing or swallowing, or swelling of the face.

Limitations

Evidence for use in otherwise healthy adults is limited, and responses vary between individuals. Compounded products are not FDA-approved. Products obtained from unverified sources may be contaminated, mislabelled, or a different substance altogether.

Alternatives worth discussing

An FDA-approved treatment for a diagnosed condition; referral to an endocrinologist; addressing nutrition, sleep and strength training alongside a broader hormone evaluation; or no treatment at all, when the evidence or the sourcing does not justify it. We will say so if that is where the evaluation lands.

Access

In-office or telehealth

Consultations and follow-up are available at our Conroe, Houston, Fulshear, Katy and Kingwood offices, and by telehealth for patients physically located in Texas, North Carolina or South Carolina, subject to law and clinical eligibility. Laboratory testing or an in-person visit may be required.

Conroe  ·  Houston  ·  Fulshear  ·  Katy

Pricing: Consultation required. Cost depends on your evaluation, laboratory testing, the pharmacy and your follow-up schedule. Cherry financing may be available for eligible patients.

Common questions

Sermorelin FAQ

Is sermorelin FDA-approved?
Sermorelin acetate was approved in 1997 under the brand name Geref, for children with growth hormone deficiency. That product is no longer manufactured, and there is no FDA-approved sermorelin product on the United States market today. When a clinician prescribes sermorelin now, it is prepared by a licensed compounding pharmacy, and compounded drugs are not FDA-approved.
Is sermorelin the same as growth hormone?
No. Sermorelin is a growth hormone–releasing hormone analogue: it signals the pituitary gland to release your own growth hormone. It is not growth hormone, and it is not prescribed as a substitute for growth hormone therapy in a diagnosed deficiency.
Do I need laboratory testing first?
Yes. A health history, a physical evaluation and baseline laboratory testing come before any prescription, and repeat testing is part of follow-up. A prescription written without them is not something we will provide.
Can this be handled by telehealth?
Consultation and follow-up are available by telehealth for patients physically located in Texas, North Carolina or South Carolina, subject to law and clinical eligibility. Some patients will need an in-person visit or local laboratory testing.
Where does the medication come from?
From a state-licensed compounding pharmacy we have verified. We do not prescribe, administer or recommend anything labelled “research use only”, and we do not work with suppliers we cannot verify.
What does it cost?
Pricing is set after your consultation, because it depends on your evaluation, laboratory testing, the pharmacy and your follow-up schedule. Cherry financing may be available for eligible patients.
Can it be combined with other medicines?
Only after a clinician has reviewed every medicine and supplement you take. Nothing should be combined on your own, and we will not add a second prescription to a plan we have not reviewed in full.

Sources & medical review

  1. Federal Register, March 4, 2013 — Determination That GEREF (Sermorelin Acetate) Injection Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
  2. U.S. Food and Drug Administration — Compounding and the FDA: Questions and Answers
  3. U.S. Food and Drug Administration — Human Drug Compounding

Medical-content evidence review: October 1, 2026. Content is written for patient education and structured from current primary regulatory and government sources. It has not been individualized to your medical history. Sermorelin is available by prescription only, following evaluation by a licensed clinician. Guidance and labeling change; a licensed Identity Aesthetics provider confirms current suitability, informed consent and treatment details before care.

Your next step

Make an informed plan

Start with a physician consultation. Bring your medication list and any laboratory results from the past year. If sermorelin is not the right fit, we will tell you, and we will talk through what is.

Continue Exploring

Check the claims before you decide.

Read how we verify a prescribed product, how we source it, and what our advertising certification covers.

Prepared byIdentity Aesthetics Clinical Editorial Team

Patient education developed from primary regulatory and government sources.

Medically reviewed byDallas Alvey, MD, DDS

Physician review of regulatory status, candidacy and risk information.

Evidence reviewOctober 16, 2026

Read our editorial standards and update policy